| Just Other Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Marketing > Long Term Residual Income Streams or Quick Hit Fast Money? |
|
Just Other Articles - Long Term Residual Income Streams or Quick Hit Fast Money?
This has been the question that all successful network marketers eventually must ask themselves. Unfortunately, you can’t have them both. Making the wrong decision on this question may provid According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product e you with an influx of temporary cash, but you will NEVER find a home. You will never be able to build a residual income stream that can be passed down to future generations. Unfortunately th ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in problem with many “Quick Hit, Fast Money” programs is they attract 2 types of network marketers, the Vultures and the Followers. Make no mistake about it, you are either one or the other. lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. hat is why people that truly care about people avoid these programs. The problem “followers” seem to have is that they seem to disassociate with reality. A $200, $500 or $1,000 fast start bon here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe s only happens when you enroll someone. It is amazing to me how people that have problems sponsoring someone into a $50, $100, or $200 a month program, suddenly feel that they are now going to d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ave the ability to load people up with products and start collecting fast money? Who are they fooling, other than themselves? This is a ridiculous, unfortunate assumption that most all “follow ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc rs” seem to make. The sad part is the vultures, who know better, support this false assumption many times knowing that the follower is struggling in their current low monthly qualification pro easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ram. Are they concerned about the “follower” or are they more focused on their quick hit, fast money commission? When you stand back and look at this situation like I have for the past 25 year nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically , the answers seem to be as clear as the nose on your face, doesn’t it? The reality is that fast money ONLY OCCURS when someone purchases more products than they really need to start their busi and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ess. The reality is that Quick Hit, Fast Money Programs always grow quickly and then fall faster than they went up. Why? Because the vultures will not stay around, they prefer to jump to the ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi next hot, quick hit, fast money program and recycle their followers. I could name literally hundreds of programs that I have seen over the years go through this exact scenario. Why am I even a ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a dressing this issue? Because these type of programs died off for awhile, and now they seem to be resurging. I feel that it is my responsibility to do my part to warn you. According to the Di dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ect Sales Association over 4,000 new network marketing companies start every year. 85% don’t last 1 year, much less 2 years, 10 years, or provide a lifetime home for their associates. Fast gr cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin wth followed by steep decline, the vultures jump ship and the followers have to make a decision, to be recycled or simply quit the industry all together. I am always amazed how followers follo tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen vultures whom they confuse as leaders. “People follow those that appear to be leaders, right wrong, good or bad” True leaders, make decisions that not only benefit themselves but also the peop t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel e that trust and depend on them, if you cross that line, you are destined to jump from quick hit fast money program to quick hit fast money program. DON’T DO IT! What do you REALLY WANT from th ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust s industry? * Are you looking for a home? * Are you looking for a company where you can develop a long-term, steady and constant residual income stream? * Are you looking for a product y y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products u can BE PROUD to represent or would you rather have a “token product” thrown into a scheme designed to just make money? I could go on and on and ask you some very important questions. But i . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de reality you need to ask yourself these questions, don’t you? If you are a good, honest, hard working, loyal person then you and I both know you need to find a home with a solid reputable compa elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip y and an awesome consumable product. Find this, then….. Stay focused, “put your hand to the plow and don’t look back” and I promise you, a long and fulfilling career. Have a great week! Dal tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Keeping a Harmonious Relationship With Clients Through Postcards Brand Identity, Branding and Brand Image
|